BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4575001)

  • 1. Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans.
    Diamond RD; Bennett JE
    J Infect Dis; 1973 Jun; 127(6):694-7. PubMed ID: 4575001
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection.
    Schimpff SC; Bennett JE
    J Allergy Clin Immunol; 1975 Jun; 55(6):430-41. PubMed ID: 1094054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection.
    Hoy JF; Murphy JW; Miller GG
    J Infect Dis; 1989 Jan; 159(1):116-9. PubMed ID: 2462601
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans.
    Fromtling RA; Kaplan AM; Shadomy HJ
    Sabouraudia; 1983 Jun; 21(2):113-9. PubMed ID: 6348975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity in Cryptococcosis.
    Graybill JR; Alford RH
    Cell Immunol; 1974 Oct; 14(1):12-21. PubMed ID: 4619352
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenic fractions of Cryptococcus neoformans.
    Graybill JR; Straus DC; Nealon TJ; Hague M; Paque RE
    Mycopathologia; 1982 Apr; 78(1):31-9. PubMed ID: 7048099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro human lymphocyte responses to Cryptococcus neoformans. Evidence for primary and secondary responses in normals and infected subjects.
    Miller GP; Puck J
    J Immunol; 1984 Jul; 133(1):166-72. PubMed ID: 6373927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.
    Fromtling RA; Blackstock R; Hall NK; Bulmer GS
    Mycopathologia; 1979 Sep; 68(3):179-81. PubMed ID: 394001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptococcal meningitis; significance of positive antigen test on undiluted spinal fluid.
    Salom IL
    N Y State J Med; 1981 Aug; 81(9):1369-70. PubMed ID: 7022273
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary cryptococcosis: atypical results in the serum test for cryptococcal antigen.
    Jenkins C; Breslin AB
    Aust N Z J Med; 1982 Oct; 12(5):527-30. PubMed ID: 6758749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of cyclosporine on interleukin-2 receptor expression stimulated by Cryptococcus neoformans.
    Miller GP; Lewis DE
    J Infect Dis; 1987 Apr; 155(4):799-802. PubMed ID: 3102632
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fever of unknown origin and cryptococcal antigen].
    Torroba Alvarez L; Fortún Abete J; Buzón Rueda L; Moreno Caparrós A
    Med Clin (Barc); 1988 Oct; 91(13):514. PubMed ID: 3067009
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunity in cryptococcosis: an overview.
    Fromtling RA; Shadomy HJ
    Mycopathologia; 1982 Mar; 77(3):183-90. PubMed ID: 7040977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    Diamond RD; May JE; Kane MA; Frank MM; Bennett JE
    J Immunol; 1974 Jun; 112(6):2260-70. PubMed ID: 4596700
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental cryptococcosis in guinea pigs.
    Riera CM; Masih DT; Nobile R
    Mycopathologia; 1983 Jun; 82(3):179-84. PubMed ID: 6350885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of mice with a mutant of Cryptococcus neoformans. Characterization of the mutant, actively acquired resistance to experimental cryptococcosis in mice.
    Reiss F; Alture-Werber E
    Dermatologica; 1976; 152(1):16-22. PubMed ID: 780165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the latex agglutination test for cryptococcal antigen in diagnosing disseminated infections with Trichosporon beigelii.
    McManus EJ; Bozdech MJ; Jones JM
    J Infect Dis; 1985 Jun; 151(6):1167-9. PubMed ID: 3889173
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental cryptococcosis in normal and B-cell-deficient mice.
    Monga DP; Kumar R; Mohapatra LN; Malaviya AN
    Infect Immun; 1979 Oct; 26(1):1-3. PubMed ID: 387600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis.
    Porter KG; Sinnamon DG; Gillies RR
    Lancet; 1977 Jun; 1(8024):1262. PubMed ID: 68362
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural cell-mediated resistance against Cryptococcus neoformans: a possible role for natural killer (NK) cells.
    Murphy JW
    Curr Top Med Mycol; 1985; 1():135-54. PubMed ID: 3916764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.